ZEROSTACK CORP
ZSTKNASDAQTrading Snapshot
- Day Range
- $4.86 – $4.97
- 52-Week Range
- $1.32 – $15.04
- Volume
- $2.61B
- Avg Volume
- $1.90B
- Shares Outstanding
- 1.0M
- Next Earnings
- Oct 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $36M
- Last Q Revenue
- $14M
- P/E Ratio
- -0.0
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-17.85
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +188.0%
Why Investors Own ZSTK
- ✓High-growth profile — revenue up -5.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 48% gross margin and 18% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ZEROSTACK CORP
ZSTK
StockOtter · stockotter.spaceAbout ZEROSTACK CORP
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Zerostack Corp. Reports Cryptocurrency Holdings with Aggregate Market Value of Approximately $1.06 Billion, Representing Approximately $18.19 Per Partially Diluted Share
Company's $4.71 Trading Share Price Represents an Approximately 74.1% Discount to the Market Value of Cryptocurrency Holdings Per Partially Diluted Share Dallas, Texas--(Newsfile Corp. - August 24, 2026) - Zerostack Corp
ZeroStack (ZSTK) Stock Skyrockets Wednesday: What's Driving the Action?
Shares of ZeroStack Corp (NASDAQ:ZSTK) are surging Wednesday afternoon after the company announced a definitive agreement for a $1 billion strategic contribution of Memecore tokens.
ZeroStack Announces US$1.0 Billion Strategic Contribution of Memecore ($M) Tokens at US$25.19 Per Share
Transaction Represents an Unprecedented Strategic Investment Premium Dallas, Texas--(Newsfile Corp. - August 19, 2026) - ZeroStack Corp. (NASDAQ: ZSTK) ("ZeroStack" or the "Company") today announced that it has entered i
ZeroStack Announces Completion of Continuance to Texas
Dallas, Texas--(Newsfile Corp. - August 18, 2026) - ZeroStack Corp. (NASDAQ: ZSTK) ("ZeroStack" or the "Company"), the first Nasdaq-listed, AI-focused asset management company, today announced that, effective August 18,
ZeroStack Announces Results of 2026 Annual and Special Meeting of Shareholders, Provides Phatebo Purchase Orders Update and Announces Closing of Previously Announced Cryptocurrency Financing
Dallas, Texas--(Newsfile Corp. - July 20, 2026) - ZeroStack Corp. (NASDAQ: ZSTK) ("ZeroStack" or the "Company"), the first Nasdaq-listed, AI-focused asset management company, held its 2026 Annual and Special Meeting of S
ZeroStack Corp. Secures Purchase Orders for up to US$14.7 Million of Inventory from Two Pharmaceutical Companies
Toronto, Ontario--(Newsfile Corp. - July 9, 2026) - ZeroStack Corp. (NASDAQ: ZSTK) (the "Company" or "ZeroStack"), the first Nasdaq-listed, AI-focused asset management company, today announced that it has secured pharmac